Access cutting-edge neovascular age-related macular degeneration (nvamd) treatment through this clinical trial at a research site in Mountain View. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Mountain View location
Preparing your pre-screening questions…
Access neovascular age-related macular degeneration (nvamd) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neovascular age-related macular degeneration (nvamd) treatment provided free
Check if you qualify for this neovascular age-related macular degeneration (nvamd) clinical trial in Mountain View, CA
No-Cost Study Care
Local to Mountain View
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema following branch retinal vein occlusion (BRVO). The study will consist of 4 patient cohorts, with participants in each cohort randomized (1:1) to either a low dose of EYE103 via IVT or a high dose of EYE103 via IVT. 40 participants will be enrolled in each cohort. Enrollment timing for each cohort will be sequenced into specific arms of the study at the Sponsor's discretion. All participants in the study will receive a total of 3 injections of EYE103 into the study eye, spaced at 4 weeks apart. All participants will return at designated time points following each injection for safety and efficacy assessments. The Week 12 Visit will serve as the end of study visit for all participants.
Sponsor: EyeBiotech Ltd.
Yes, this clinical trial (NCT07205887) has an active research site in Mountain View, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for neovascular age-related macular degeneration (nvamd) treatment options in Mountain View, CA, this clinical trial (NCT07205887) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mountain View research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neovascular age-related macular degeneration (nvamd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all neovascular age-related macular degeneration (nvamd) clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Mountain View — not just this study.
Browse Rheumatoid Arthritis Trials in Mountain View →